Obesity: Scope, Lifestyle Interventions, and Medical Management

被引:44
作者
McCafferty, Benjamin J. [1 ]
Hill, James O. [2 ]
Gunn, Andrew J. [3 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Radiol, Div Vasc & Intervent Radiol, Birmingham, AL USA
关键词
Obesity; diet; physical activity; pharmacology for obesity; BODY-MASS INDEX; PHYSICAL-ACTIVITY; WEIGHT-LOSS; POOLED ANALYSIS; ADIPOSE-TISSUE; US ADULTS; OVERWEIGHT; DISEASE; LEPTIN; RISK;
D O I
10.1016/j.tvir.2020.100653
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Obesity is a public health epidemic in the United States, with implications for patients across many organ systems. Despite improvements in understanding the pathophysiology and increasing number of therapies for obesity, its prevalence continues to rise. The purpose of this review is to provide the interventional radiologist with an understanding of (1) the epidemiology of obesity; (2) the impact of obesity on patients and the healthcare system; (3) the causes of obesity; (4) conservative management of obesity; and (5) pharmacologic management of obesity. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:8
相关论文
共 75 条
[1]   Derivation and validation of simple anthropometric equations to predict adipose tissue mass and total fat mass with MRI as the reference method [J].
Al-Gindan, Yasmin Y. ;
Hankey, Catherine R. ;
Govan, Lindsay ;
Gallagher, Dympna ;
Heymsfield, Steven B. ;
Lean, Michael E. J. .
BRITISH JOURNAL OF NUTRITION, 2015, 114 (11) :1852-1867
[2]   Economic Costs of Diabetes in the U.S. in 2012 [J].
Yang W. ;
Dall T.M. ;
Halder P. ;
Gallo P. ;
Kowal S.L. ;
Hogan P.F. ;
Petersen M. .
DIABETES CARE, 2013, 36 (04) :1033-1046
[3]   State-Level Estimates of Obesity-Attributable Costs of Absenteeism [J].
Andreyeva, Tatiana ;
Luedicke, Joerg ;
Wang, Y. Claire .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 56 (11) :1120-1127
[4]  
[Anonymous], COST DIAB
[5]  
[Anonymous], 2017, NAT DIAB STAT REP
[6]  
[Anonymous], IMPR YOUR EAT HAB J
[7]   Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline [J].
Apovian, Caroline M ;
Aronne, Louis J. ;
Bessesen, Daniel H. ;
McDonnell, Marie E. ;
Murad, M. Hassan ;
Pagotto, Uberto ;
Ryan, Donna H. ;
Still, Christopher D. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02) :342-362
[8]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[9]   Inhibition of food intake in obese subjects by peptide YY3-36 [J].
Batterham, RL ;
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Withers, DJ ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (10) :941-948
[10]   Two anti-obesity hopefuls and their safety [J].
Bello, Nicholas T. ;
Campbell, Sara C. .
EXPERT OPINION ON DRUG SAFETY, 2012, 11 (05) :681-683